Top drugs earned billions for Mass. biotechs in 2018

Treatments for everything from Attention Deficit Hyperactivity Disorder (ADHD) to multiple sclerosis topped the sales charts in 2018, according to an analysis of corporate financial reports by the Business Journal. But drug prices are under a more focused microscope than ever by state and federal policymakers. Lawmakers and advocates are expected to outline a plan for prescription drug-pricing reform at the Massachusetts State House on Tuesday.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news